Centre of Evidence Based Dermatology
  • Print
   
   

Clinical trial to test two treatments for vitiligo sufferers

 

 People who suffer from the skin condition ‘vitiligo’ are being encouraged to take part in a clinical trial led by The University of Nottingham’s Centre of Evidence Based Dermatology and the Nottingham Clinical Trials Unit

Vitiligo is a condition that affects the pigmentation of the skin, causing white patches to appear on the skin of people of all ages and skin colours. It affects up to 1 per cent of the population worldwide and up to now, treatment has been limited and the effectiveness of some treatments has not been tested in large studies. 

The HI-Light Vitiligo Trial, funded by the National Institute for Health Research (NIHR)’s Health Technology Assessment Programme, aims to test two commonly used treatments – steroid cream and light treatment using a hand-held narrow band UVB light. The research team is looking for 440 children (five years and above) and adults with vitiligo across the UK to take part in the study, using treatments for nine months and then being followed up to assess long term treatment effects. 

Read more  and/or visit the HI-Light Study webpage

Posted on Thursday 16th June 2016

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk